| Literature DB >> 26016477 |
Lin Sun1,2, Qiang Zhang3, Heng'an Ge4, Yeqing Sun5, Biao Cheng6.
Abstract
BACKGROUND: Tear conversion followed by repair and trans-tendon techniques have been widely used for partial-thickness rotator cuff tears. Both of them showed favorable results with regard to the management of articular-sided partial-thickness rotator cuff tears (PTRCTs) of more than 50% thickness. However, controversy continues with the best management. This study aims to compare the clinical outcomes between the two techniques.Entities:
Mesh:
Year: 2015 PMID: 26016477 PMCID: PMC4450842 DOI: 10.1186/s13018-015-0224-6
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Search strategy flow diagram
The characteristics of the included studies
| Study | Year | Country | Study design | Patients | Intervention | Sample size | Mean follow-up | Mean age | Gender (male/female) | Matching outcome measures |
|---|---|---|---|---|---|---|---|---|---|---|
| Allen Deutsch | 2007 | USA | Prospective cohort study | Articular side partial-thickness rotator cuff tears (>50 %) | TCaR | 33 | 38 months | 48 | 22/11 | ASES |
| Castricini R | 2009 | Italy | Retrospectively cohort study | Articular side partial-thickness rotator cuff tears (>52 %) | TTR | 31 | 33 months | 53.3 | 16/15 | Re-tear rate |
| Jaideep J. Iyengar | 2010 | USA | Retrospectively cohort study | Articular side partial-thickness rotator cuff tears (>52 %) | TCaR | 14 | 24 months | 57.5 | Unclear | Re-tear rate |
| Young-Jin Seo | 2011 | Korea | Prospective cohort study | Articular side partial-thickness rotator cuff tears (>50 %) | TTR | 24 | 12 months | 51 | 14/10 | ASES |
| Sang-Jin Shin | 2012 | Korea | RCT | Articular side partial-thickness rotator cuff tears (>50 %) | TTR | 24 | 31 months | 53 | 10/14 | ASES, Re-tear rate |
| Sang-Jin Shin | 2012 | Korea | RCT | Articular side partial-thickness rotator cuff tears (>50 %) | TCaR | 24 | 31 months | 57 | 13/11 | ASES, Re-tear rate |
| Xavier A. Duralde | 2012 | USA | Retrospectively cohort study | Articular side partial-thickness rotator cuff tears (>50 %) | TTR | 50 | 38 months | 48.7 | Unclear | ASES |
| Kyung Cheon Kim | 2013 | Korea | Prospective cohort study | Articular side partial-thickness rotator cuff tears (>50 %) | TTR | 32 | 17.4 months | 51.8 | 16/16 | ASES |
| Francesco Franceschi | 2013 | Italy | RCT | Articular side partial-thickness rotator cuff tears (>50 %) | TCaR | 28 | 39 months | 55.6 | 13/15 | ASES, Re-tear rate |
| Francesco Franceschi | 2013 | Italy | RCT | Articular side partial-thickness rotator cuff tears (>50 %) | TTR | 32 | 38 months | 57.3 | 18/14 | ASES, Re-tear rate |
| Sung-Jae Kim | 2013 | Korea | Case–control study | Articular side partial-thickness rotator cuff tears (>50 %) | TTR | 29 | 24 months | 59.1 | 10/19 | ASES, Re-tear rate |
TCaR tear conversion and repair, TTR trans-tendon repair
The methodological quality of the included studies
| Item | Deutsch 2007 | Kim 2013 | Franceschi 2013 | Kim 2013 | Duralde 2012 | Shin 2012 | Seo 2011 | Iyengar 2010 | Castricini 2009 |
|---|---|---|---|---|---|---|---|---|---|
| 1) Is the hypothesis/aim/objective of the study clearly described? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 2) Are the main outcomes to be measured clearly described in the Introduction or Method’s section? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 3) Are the characteristics of the patients included in the study clearly described? | Y | Y | Y | Y | N | Y | N | Y | N |
| 4) Are the interventions of interest clearly described? | N | Y | Y | N | N | Y | N | N | N |
| 5) Are the distributions of principal confounders in each group of subjects to be compared clearly described? | N | N | N | N | N | N | N | N | N |
| 6) Are the main findings of the study clearly described? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 7) Does the study provide estimates of the random variability in the data for the main outcomes? | N | Y | Y | Y | Y | Y | Y | Y | Y |
| 8) Have all important adverse events that may be a consequence of the intervention been reported? | N | N | N | N | N | N | N | N | N |
| 9) Have the characteristics of patients lost to follow-up been described? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 10) Have actual probability values been reported (e.g., 0.035 rather than <0.05) for the main outcomes except where the probability value is less than 0.001? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 11) Were the subjects asked to participate in the study representative of the entire population from which they were recruited? | U | U | U | U | U | U | U | U | U |
| 12) Were those subjects who were prepared to participate representative of the entire population from which they were recruited? | U | U | U | U | U | U | U | U | U |
| 13) Were the staff, places, and facilities where the patients were treated representative of the treatment the majority of patients receive? | U | U | U | U | U | U | U | U | U |
| 14) Was an attempt made to blind study subjects to the intervention they have received? | N | N | U | N | N | U | N | N | N |
| 15) Was an attempt made to blind those measuring the main outcomes of the intervention? | N | N | Y | N | N | Y | N | N | N |
| 16) If any of the results of the study were based on “data dredging”, was this made clear? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 17) In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case–control studies, is the time period between the intervention and outcome the same for cases and controls? | N | Y | N | N | N | N | Y | N | N |
| 18) Were the statistical tests used to assess the main outcomes appropriate? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 19) Was compliance with the intervention/s reliable? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 20) Were the main outcome measures used accurate (valid and reliable)? | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 21) Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited from the same population? | N | Y | Y | N | N | Y | N | N | N |
| 22) Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited over the same period of time? | N | Y | Y | N | N | Y | N | N | N |
| 23) Were study subjects randomized to intervention groups? | N | N | Y | N | N | Y | N | N | N |
| 24) Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable? | N | N | U | N | N | U | N | N | N |
| 25) Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? | N | N | N | N | N | N | N | N | N |
| 26) Were losses of patients to follow-up taken into account? | N | N | N | N | N | Y | Y | Y | N |
| 27) Did the study have sufficient power to detect a clinically important effect where the probability value for a different being due to chance is less than 5 %? | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Score | 10 | 15 | 16 | 11 | 10 | 17 | 12 | 12 | 10 |
Y yes, N No, U unable to determine
Fig. 2Difference of the ASES scale: the forest plots present the mean ASES score of each study. Each square represents the individual study’s mean score with a 95 % CI indicated by the horizontal lines. Number of included studies: TCaR, n = 3; TTR, n = 6. Mean TCaR, 89.503; TTR, 88.722. Heterogeneity (I 2): TCaR = 45.573, TTR = 39.308. Significance: P = 0.69
Fig. 3Difference of the re-tear rate: the forest plots present the mean re-tear rate of each study. Each square represents the individual study’s mean rate with a 95 % CI indicated by the horizontal lines. Number of included studies: TCaR, n = 3; TTR, n = 4. Mean TCaR, 0.105; TTR, 0.043. Heterogeneity (I 2): TCaR = 34.3, TTR = 0. Significance: P <0.001